The dedicated hub for news and updates coming directly out of the Technion – Israel Institute of Technology.
Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early‑stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most patients do not benefit from it and may experience significant short‑ and long‑term side effects. The central challenge is identifying, at the time of diagnosis, which patients are likely to benefit, and which are not.
How has evolution shaped viral infection? How does humanity cope with viral diseases? Why do vaccines work well against one disease but not another? Why are drugs that work against bacteria ineffective against viruses? And how optimistic can we allow ourselves to be about the future? These questions were addressed recently by Dr. Yotam Bar-On of the Ruth and Bruce Rappaport Faculty of Medicine at a Technion event.
Groundbreaking research reveals a self-regulating, implantable living technology that could offer hope for millions with diabetes and other chronic diseases.
The special collaboration will help advance Israeli innovation, energy security, and civil aviation. After concluding the project feasibility study, Boeing and the Technion announced advancement to the next stage of practical development.
Technion has inaugurated a newly upgraded VLSI Laboratory for chip design with a $1 million investment from Apple, Intel and NVIDIA. The facility will support advanced research in integrated circuits, AI-focused hardware and energy-efficient systems while strengthening collaboration between academia and industry.
Technion has inaugurated a newly upgraded VLSI Laboratory for chip design with a $1 million investment from Apple, Intel and NVIDIA. The facility will support advanced research in integrated circuits, AI-focused hardware and energy-efficient systems while strengthening collaboration between academia and industry.
Last week, the Technion marked 25 years since the invention of the portable storage device – the Disk On Key – in a special event with Technion alumnus Dov Moran, the inventor of the USB flash drive.
Thinking about where to study for a thriving career? Discover why the Technion stands out: leading‑edge programs, real‑world innovation, and access to global opportunities that help ambitious students succeed.
The Technion has awarded the Harvey Prize to two leading American scientists whose breakthroughs in nanotechnology and medicine are shaping the future of global research and innovation.
The Ruth and Bruce Rappaport Faculty of Medicine inaugurated a new complex for its Teaching and Medical Education Division, established through the generous contribution of Professor Emeritus John Finberg — one of the faculty’s veterans and a co-developer of the first-ever drug shown to slow the progression of Parkinson’s disease.
Former German Chancellor Dr Angela Merkel visited the Technion, meeting students and researchers, touring key labs, and highlighting the deep scientific partnership between Israel and Germany.
Amid rising antisemitism abroad, the Technion has launched a pioneering program welcoming 26 students from eight countries. With English instruction, Hebrew ulpan, mentorship, and academic support, it offers a safe, world-class path to degree studies in Israel.
